CARA Act – Comprehensive Addiction and Recovery Act of 2016

 

The purpose of this program is to prevent and reduce the abuse of opioids or methamphetamines and the abuse of prescription medications among youth ages 12-18 in communities throughout the United States Grants awarded through the CARA Act are intended as an enhancement to current or formerly funded Drug-Free Communities (DFC) Support Program grant award recipients as established community-based youth substance use prevention coalitions capable of effecting community-level change. For the purposes of this FOA and the DFC Support Program, a coalition is defined as a community-based formal arrangement for cooperation and collaboration among groups or sectors of a community in which each group retains its identity, but all agree to work together toward a common goal of building a safe, healthy, and drug-free community. CARA grant award recipients, also referred to as recipients, are expected to conduct the day-to-day operations of the grant program. CARA recipients are not permitted to serve as a conduit for CARA funds passing through them or to another agency. Coalitions receiving CARA Act funds, as current or formerly funded DFC recipients, are expected to work with leaders in their communities to identify and address local youth opioid, methamphetamine, and/or prescription medication abuse and create sustainable community-level change. Additionally, recipients are expected to implement comprehensive community-wide strategies.

Active 93.799 Centers For Disease Control and Prevention, Department of Health and Human Services A - Formula Grants; B - Project Grants Not applicable. CARA Act - Comprehensive Addiction and Recovery Act of 2016, Title 1, Section 103, Public Law 114-198, 42 U.S.C. 201
Drug-Free Communities Act, 21 USC 1531 et seq.,P.L.105-20
The goal of this program is to prevent and reduce the abuse of opioids or methamphetamines and the abuse of prescription medications among youth ages 12-18 in communities throughout the United States. The statutory authority for this program, 42 USC 1536 of the Comprehensive Addiction and Recovery Act, limits eligibility to domestic public and private nonprofit entities that are current or former Drug-Free Communities (DFC) Support Program recipients. Eligible applicants are community-based coalitions addressing local youth opioid, methamphetamine, and/or prescription medication abuse. Reference posted NOFOs available on grants.gov. The purpose of this program is to prevent and reduce the abuse of opioids or methamphetamines and the abuse of prescription medications among youth ages 12-18 in communities throughout the United States *For the purposes of this NOFO, "youth" is defined as individuals 18 years of age and younger. Any required credentials and/or documentation will be identified in the specific Notice of Funding Opportunity (NOFO) for this Assistance Listing. Preapplication coordination is required. This program is eligible for coverage under E.O. 12372, "Intergovernmental Review of Federal Programs." An applicant should consult the office or official designated as the single point of contact in his or her State for more information on the process the State requires to be followed in applying for assistance, if the State has selected the program for review. This grant program is covered under Executive Order (EO) 12372, as implemented through Department of Health and Human Services (DHHS) regulation at 45 CFR Part 100. Under this Order, states may design their own processes for reviewing and commenting on proposed federal assistance under covered programs. Certain jurisdictions have elected to participate in the EO process and have established State Single Points of Contact (SPOCs). This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. After review and approval, a Notice of Award (NoA) will be prepared and processed, along with appropriate notification to the public. Initial awards provide funds for the first budget period (usually 12 months) and the NoA will indicate support recommended for the remainder of the project period, allocation of Federal funds by budget categories, award requirements, and special conditions, if any. Check Grants.gov for any relevant NOFO information regarding processes for applying for assistance. From 60 to 90 days. Not applicable. Project period of performance is 1 to 5 years. After initial awards, and subject to availability of funds, projects may be continued non-competitively contingent upon satisfactory progress by the recipient (as documented in required reports) and the determination that continued funding is in the best interest of the Federal government. Applications will be evaluated on the review criteria described in the Notice of Funding Opportunity Announcements (NOFOs). In general, the review and selection process of complete and responsive applications to the NOFO consists of determination of the scientific and technical merit by objective or peer review, availability of funds, and relevance of program priorities and the priorities of CDC. Allowable Activities CARA grants awarded through this program are intended to: •Enhance the ability of established community organizations to create community-level change regarding opioids or methamphetamines and the abuse of prescription medications. •Strengthen collaboration among communities, the federal government, state, local, and tribal governments to reduce the use of opioids or methamphetamines and the abuse of prescription medications among youth within the area served by the coalition. •Enhance intergovernmental cooperation and coordination on the issue of opioids or methamphetamines and the abuse of prescription medications among youth. •Develop a comprehensive community-wide action plan to address the issue of opioids or methamphetamines and the abuse of prescription medications among youth. The types of activities that are expected and allowable include, but are not limited to: •data collection to better understand the current local youth opioid, methamphetamine, and/or prescription medication abuse issues in the community; •community education on the dangers of opioid, methamphetamine, and/or prescription medication abuse; •prescriber education and training; •awareness and availability of naloxone/narcan policies; •increase awareness and availability of safe storage and prescription drug disposal options; •promotion of proper usage of Presciption Drug Monitoring Programs (PDMP); and/or •seek specialized training and technical assistance to help increase the effectiveness of community anti-drug coalitions. Performance Reports: Annual Federal Financial Reports (FFR) and performance/progress reports are required. Final FFRs and performance reports are required. Other reporting may be required and will be outlined in the NOFO or the Notice of Award. Not applicable. In accordance with 2 CFR ?200, as codified in 45 CFR ?75, there is a 3-year record retention requirement; records shall be retained beyond the 3-year period if final audit has not been done or findings resolved. Property records must be retained in accordance with HHS Grants Policy Statement requirements. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is provided for a 12-month budget period with a period of performance of up to five years subject to the availability of funds and satisfactory progress of the recipient. Notice of Award (NOA) None/Not specified. Christi Jones, Deputy Branch Chief
4770 Buford Hwy., MS S106-2
Atlanta, GA 30341 USA
buv3@cdc.gov
Phone: 770.488.3703

Toni Augustus-High
4770 Buford Hwy NE, MS-S106-2
Atlanta, GA 30341 USA
wef9@cdc.gov
Phone: 770.488.2906 https://www.cdc.gov 75-0952-0-1-551 (Formula Grants) FY 22$3,149,404.00; FY 23 est $3,199,404.00; FY 24 est $3,199,403.00; FY 19$2,744,145.00; FY 20 est $2,744,729.00; FY 21 est $0.00; FY 18$2,744,145.00; - Anticipated Total Available Funding:$2,750,000 Estimated Award Amount:Up to $50,000 Not applicable. Not applicable.